Cargando…

The impact of integrated disease management in high-risk COPD patients in primary care

Patients with chronic obstructive pulmonary disease (COPD) have a reduced quality of life (QoL) and exacerbations that drive health service utilization (HSU). A majority of patients with COPD are managed in primary care. Our objective was to evaluate an integrated disease management, self-management...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrone, Madonna, Masciantonio, Marcello G., Malus, Natalie, Stitt, Larry, O’Callahan, Tim, Roberts, Zofe, Johnson, Laura, Samson, Jim, Durocher, Lisa, Ferrari, Mark, Reilly, Margo, Griffiths, Kelly, Licskai, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438975/
https://www.ncbi.nlm.nih.gov/pubmed/30923313
http://dx.doi.org/10.1038/s41533-019-0119-9
_version_ 1783407184917299200
author Ferrone, Madonna
Masciantonio, Marcello G.
Malus, Natalie
Stitt, Larry
O’Callahan, Tim
Roberts, Zofe
Johnson, Laura
Samson, Jim
Durocher, Lisa
Ferrari, Mark
Reilly, Margo
Griffiths, Kelly
Licskai, Christopher J.
author_facet Ferrone, Madonna
Masciantonio, Marcello G.
Malus, Natalie
Stitt, Larry
O’Callahan, Tim
Roberts, Zofe
Johnson, Laura
Samson, Jim
Durocher, Lisa
Ferrari, Mark
Reilly, Margo
Griffiths, Kelly
Licskai, Christopher J.
author_sort Ferrone, Madonna
collection PubMed
description Patients with chronic obstructive pulmonary disease (COPD) have a reduced quality of life (QoL) and exacerbations that drive health service utilization (HSU). A majority of patients with COPD are managed in primary care. Our objective was to evaluate an integrated disease management, self-management, and structured follow-up intervention (IDM) for high-risk patients with COPD in primary care. This was a one-year multi-center randomized controlled trial. High-risk, exacerbation-prone COPD patients were randomized to IDM provided by a certified respiratory educator and physician, or usual physician care. IDM received case management, self-management education, and skills training. The primary outcome, COPD-related QoL, was measured using the COPD Assessment Test (CAT). Of 180 patients randomized from 8 sites, 81.1% completed the study. Patients were 53.6% women, mean age 68.2 years, post-bronchodilator FEV(1) 52.8% predicted, and 77.4% were Global Initiative for Obstructive Lung Disease Stage D. QoL-CAT scores improved in IDM patients, 22.6 to 14.8, and worsened in usual care, 19.3 to 22.0, adjusted difference 9.3 (p < 0.001). Secondary outcomes including the Clinical COPD Questionnaire, Bristol Knowledge Questionnaire, and FEV1 demonstrated differential improvements in favor of IDM of 1.29 (p < 0.001), 29.6% (p < 0.001), and 100 mL, respectively (p = 0.016). Compared to usual care, significantly fewer IDM patients had a severe exacerbation, −48.9% (p < 0.001), required an urgent primary care visit for COPD, −30.2% (p < 0.001), or had an emergency department visit, −23.6% (p = 0.001). We conclude that IDM self-management and structured follow-up substantially improved QoL, knowledge, FEV1, reduced severe exacerbations, and HSU, in a high-risk primary care COPD population. Clinicaltrials.gov NCT02343055.
format Online
Article
Text
id pubmed-6438975
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64389752019-04-01 The impact of integrated disease management in high-risk COPD patients in primary care Ferrone, Madonna Masciantonio, Marcello G. Malus, Natalie Stitt, Larry O’Callahan, Tim Roberts, Zofe Johnson, Laura Samson, Jim Durocher, Lisa Ferrari, Mark Reilly, Margo Griffiths, Kelly Licskai, Christopher J. NPJ Prim Care Respir Med Article Patients with chronic obstructive pulmonary disease (COPD) have a reduced quality of life (QoL) and exacerbations that drive health service utilization (HSU). A majority of patients with COPD are managed in primary care. Our objective was to evaluate an integrated disease management, self-management, and structured follow-up intervention (IDM) for high-risk patients with COPD in primary care. This was a one-year multi-center randomized controlled trial. High-risk, exacerbation-prone COPD patients were randomized to IDM provided by a certified respiratory educator and physician, or usual physician care. IDM received case management, self-management education, and skills training. The primary outcome, COPD-related QoL, was measured using the COPD Assessment Test (CAT). Of 180 patients randomized from 8 sites, 81.1% completed the study. Patients were 53.6% women, mean age 68.2 years, post-bronchodilator FEV(1) 52.8% predicted, and 77.4% were Global Initiative for Obstructive Lung Disease Stage D. QoL-CAT scores improved in IDM patients, 22.6 to 14.8, and worsened in usual care, 19.3 to 22.0, adjusted difference 9.3 (p < 0.001). Secondary outcomes including the Clinical COPD Questionnaire, Bristol Knowledge Questionnaire, and FEV1 demonstrated differential improvements in favor of IDM of 1.29 (p < 0.001), 29.6% (p < 0.001), and 100 mL, respectively (p = 0.016). Compared to usual care, significantly fewer IDM patients had a severe exacerbation, −48.9% (p < 0.001), required an urgent primary care visit for COPD, −30.2% (p < 0.001), or had an emergency department visit, −23.6% (p = 0.001). We conclude that IDM self-management and structured follow-up substantially improved QoL, knowledge, FEV1, reduced severe exacerbations, and HSU, in a high-risk primary care COPD population. Clinicaltrials.gov NCT02343055. Nature Publishing Group UK 2019-03-28 /pmc/articles/PMC6438975/ /pubmed/30923313 http://dx.doi.org/10.1038/s41533-019-0119-9 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ferrone, Madonna
Masciantonio, Marcello G.
Malus, Natalie
Stitt, Larry
O’Callahan, Tim
Roberts, Zofe
Johnson, Laura
Samson, Jim
Durocher, Lisa
Ferrari, Mark
Reilly, Margo
Griffiths, Kelly
Licskai, Christopher J.
The impact of integrated disease management in high-risk COPD patients in primary care
title The impact of integrated disease management in high-risk COPD patients in primary care
title_full The impact of integrated disease management in high-risk COPD patients in primary care
title_fullStr The impact of integrated disease management in high-risk COPD patients in primary care
title_full_unstemmed The impact of integrated disease management in high-risk COPD patients in primary care
title_short The impact of integrated disease management in high-risk COPD patients in primary care
title_sort impact of integrated disease management in high-risk copd patients in primary care
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438975/
https://www.ncbi.nlm.nih.gov/pubmed/30923313
http://dx.doi.org/10.1038/s41533-019-0119-9
work_keys_str_mv AT ferronemadonna theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT masciantoniomarcellog theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT malusnatalie theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT stittlarry theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT ocallahantim theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT robertszofe theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT johnsonlaura theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT samsonjim theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT durocherlisa theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT ferrarimark theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT reillymargo theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT griffithskelly theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT licskaichristopherj theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT ferronemadonna impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT masciantoniomarcellog impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT malusnatalie impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT stittlarry impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT ocallahantim impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT robertszofe impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT johnsonlaura impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT samsonjim impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT durocherlisa impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT ferrarimark impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT reillymargo impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT griffithskelly impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT licskaichristopherj impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare
AT impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare